Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...
Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback